KLTO vs. PASG, JATT, SRZN, OKYO, OMGA, SABS, CGTX, CVM, INKT, and CRIS
Should you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Passage Bio (PASG), JATT Acquisition (JATT), Surrozen (SRZN), OKYO Pharma (OKYO), Omega Therapeutics (OMGA), SAB Biotherapeutics (SABS), Cognition Therapeutics (CGTX), CEL-SCI (CVM), MiNK Therapeutics (INKT), and Curis (CRIS). These companies are all part of the "biological products, except diagnostic" industry.
Klotho Neurosciences vs.
Klotho Neurosciences (NASDAQ:KLTO) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking.
Klotho Neurosciences' return on equity of 0.00% beat Passage Bio's return on equity.
Passage Bio has a consensus target price of $7.75, suggesting a potential upside of 1,187.38%. Given Passage Bio's stronger consensus rating and higher probable upside, analysts clearly believe Passage Bio is more favorable than Klotho Neurosciences.
20.1% of Klotho Neurosciences shares are owned by institutional investors. Comparatively, 53.5% of Passage Bio shares are owned by institutional investors. 2.0% of Klotho Neurosciences shares are owned by company insiders. Comparatively, 4.3% of Passage Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Klotho Neurosciences' average media sentiment score of 0.00 beat Passage Bio's score of -0.22 indicating that Klotho Neurosciences is being referred to more favorably in the media.
Passage Bio received 52 more outperform votes than Klotho Neurosciences when rated by MarketBeat users.
Summary
Passage Bio beats Klotho Neurosciences on 6 of the 10 factors compared between the two stocks.
Get Klotho Neurosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Klotho Neurosciences Competitors List
Related Companies and Tools
This page (NASDAQ:KLTO) was last updated on 1/22/2025 by MarketBeat.com Staff
Free KLTO Stock Alerts